Illumina, Inc
Competitive intelligence and market positioning for Illumina, Inc across 3 market research reports.
3 Reports
2 Industries
HealthcarePharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics
Reports Featuring Illumina, Inc
Bioengineering
Healthcare·Market: $295.88B·CAGR: 17.53
Personalized Cancer Medicine
Healthcare·Market: $198.16B·CAGR: 10.80
Direct to Consumer Genetic Sequencing Market to Reach USD 4.7 Billion by 2033 at 7.2% CAGR
Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics·Market: USD 2.7 Billion (2025)·CAGR: 7.2%
Explore More Companies
Browse competitive intelligence on all key market players across our research coverage.
View all companies